Cronos (CRON) Free Cash Flow Growth (3y) (2022 - 2026)
Cronos (CRON) Free Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | 39.19% |
| 10 | Cronos | 1.08 Bn | 257.46 Mn | 19.15 Mn | 29.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.78% |
| Dec 31, 2025 | 33.74% |
| Sep 30, 2025 | 38.43% |
| Jun 30, 2025 | 62.15% |
| Mar 31, 2025 | 20.56% |
| Dec 31, 2024 | 28.36% |
| Sep 30, 2024 | 29.13% |
| Jun 30, 2024 | 26.51% |
| Mar 31, 2024 | 58.07% |
| Dec 31, 2023 | 32.42% |
| Sep 30, 2023 | 80.95% |
| Jun 30, 2023 | 35.82% |
| Mar 31, 2023 | -2.29% |
| Dec 31, 2022 | 23.59% |
| Sep 30, 2022 | 28.34% |
| Jun 30, 2022 | 29.55% |
| Mar 31, 2022 | -13.06% |